In vitro, Muscarella et al. reported that approximately 50% of NSCLC and 42% of SCLC cell lines showed a global DNA methylation at the KEAP1 promoter, thus reducing gene expression. This evidence concerns the gene KEAP1 and small cell lung carcinoma.